Correlation Between Goldman Sachs and IShares Genomics
Can any of the company-specific risk be diversified away by investing in both Goldman Sachs and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goldman Sachs and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Goldman Sachs Future and iShares Genomics Immunology, you can compare the effects of market volatilities on Goldman Sachs and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goldman Sachs with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goldman Sachs and IShares Genomics.
Diversification Opportunities for Goldman Sachs and IShares Genomics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Goldman and IShares is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Goldman Sachs Future and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and Goldman Sachs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goldman Sachs Future are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of Goldman Sachs i.e., Goldman Sachs and IShares Genomics go up and down completely randomly.
Pair Corralation between Goldman Sachs and IShares Genomics
Given the investment horizon of 90 days Goldman Sachs Future is expected to under-perform the IShares Genomics. But the etf apears to be less risky and, when comparing its historical volatility, Goldman Sachs Future is 2.48 times less risky than IShares Genomics. The etf trades about -0.34 of its potential returns per unit of risk. The iShares Genomics Immunology is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 2,276 in iShares Genomics Immunology on November 3, 2024 and sell it today you would earn a total of 11.00 from holding iShares Genomics Immunology or generate 0.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 60.0% |
| Values | Daily Returns |
Goldman Sachs Future vs. iShares Genomics Immunology
Performance |
| Timeline |
| Goldman Sachs Future |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| iShares Genomics Imm |
Goldman Sachs and IShares Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Goldman Sachs and IShares Genomics
The main advantage of trading using opposite Goldman Sachs and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goldman Sachs position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.| Goldman Sachs vs. Goldman Sachs ETF | Goldman Sachs vs. Goldman Sachs Future | Goldman Sachs vs. Goldman Sachs Future | Goldman Sachs vs. Goldman Sachs Future |
| IShares Genomics vs. Global X Genomics | IShares Genomics vs. iShares Cybersecurity and | IShares Genomics vs. iShares Self Driving EV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |